| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/03/1997 | EP0792167A1 Monofunctional and/or polyfunctional polylysine conjugates |
| 09/03/1997 | EP0792166A1 Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand |
| 09/03/1997 | EP0792165A1 Immunogenic compositions |
| 09/03/1997 | EP0792164A1 Composition, device, and method for enhanced electrotransport agent delivery |
| 09/03/1997 | EP0792158A1 Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 09/03/1997 | EP0792149A2 Oral compositions containing ondansetron |
| 09/03/1997 | EP0792147A1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs |
| 09/03/1997 | EP0792145A1 Transdermal resorption of active substances from supercooled masses |
| 09/03/1997 | EP0792142A1 Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| 09/03/1997 | EP0792137A1 Antifungal treatment of nails |
| 09/03/1997 | EP0792110A1 Silicone compositions |
| 09/03/1997 | EP0755672B1 Silicon composition containing a water-sensitive agent |
| 09/03/1997 | EP0576521B1 Improvements in or relating to contrast agents |
| 09/03/1997 | EP0572627B1 Solvent system to be enclosed in capsules |
| 09/03/1997 | CN1158619A Delivery of nucleic acids |
| 09/03/1997 | CN1158572A Peroral immunogen compsn. and process for producing the same |
| 09/03/1997 | CN1158334A Comptothecin derivatives |
| 09/02/1997 | US5663460 Liquid l-n-menthol composition and process for preparing the same |
| 09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/02/1997 | US5663306 Method of conjugating an activated ester to an amine-containing biological material |
| 09/02/1997 | US5663198 Drug formulations comprising coated, very sparingly water-soluble drugs for inhalational pharmaceutical forms, and process for their preparation |
| 09/02/1997 | US5663170 Diabetes |
| 09/02/1997 | US5663156 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 09/02/1997 | US5663141 Hirudin/polyalkylene glycol conjugates and hirudin muteins |
| 09/02/1997 | US5663069 Modified lambda bacteriophage |
| 09/02/1997 | US5662938 Polymers of glycolic and/or lactic acid, drug delivery, sustained release |
| 09/02/1997 | US5662933 Sustained release drugs with gels |
| 09/02/1997 | US5662932 Particles with a core of lipid surrounded by phospholipid envelope; drug delivery |
| 09/02/1997 | US5662923 Self-adhesive |
| 09/02/1997 | US5662920 Nicotine lozenge and therapeutic method for smoking cessation |
| 09/02/1997 | US5662919 Hydrolytic stability of drugs using sulfated polyvinyl alcohol copolymers |
| 09/02/1997 | US5662918 Bone disorders, storage stable |
| 09/02/1997 | US5662913 Antimicrobial compositions useful for medical applications |
| 09/02/1997 | US5662909 Potentiation of immunogenic response |
| 09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
| 09/02/1997 | CA1339415C Detection and treatment of infections with immunoconjugates |
| 08/28/1997 | WO1997031021A1 Oral calcitonin preparation and method for recovering calcitonin from eggshells |
| 08/28/1997 | WO1997030975A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/1997 | WO1997030731A2 Method of preparing polynucleotide-carrier complexes for delivery to cells |
| 08/28/1997 | WO1997030730A1 Fine grain carriers and medicinal composition prepared with the use of the same |
| 08/28/1997 | WO1997030728A1 Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
| 08/28/1997 | WO1997030726A1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 08/28/1997 | WO1997030721A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/28/1997 | WO1997030720A1 Method of producing an enterosorbent |
| 08/28/1997 | WO1997030705A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 08/28/1997 | WO1997030699A2 Dosage form of ibuprofen |
| 08/28/1997 | WO1997030692A1 Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin |
| 08/28/1997 | WO1997030656A1 Male contraceptive implant |
| 08/28/1997 | WO1997030601A1 Liquid oral compositions comprising a calcium compound and an acidulant |
| 08/28/1997 | WO1997030598A1 Caramels containing a sweetener |
| 08/28/1997 | WO1997019702A3 Powdery iodine complexes |
| 08/28/1997 | WO1997019701A3 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 08/28/1997 | WO1997019180A3 Vector consisting of a transcriptional regulatory DNA sequence linked to a DNA sequence encoding beta-lactamase for enzyme prodrug therapy |
| 08/28/1997 | WO1997009068A3 Interactive molecular conjugates |
| 08/28/1997 | DE19606968A1 Karamellen enthaltend ein Süßungsmittel Caramels containing a sweetener |
| 08/28/1997 | CA2247481A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 08/28/1997 | CA2245522A1 Particulate carriers and pharmaceutical compositions containing the same |
| 08/27/1997 | EP0791068A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
| 08/27/1997 | EP0790837A1 Oligonucleotide-dendrimer conjugates |
| 08/27/1997 | EP0790835A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 08/27/1997 | EP0790822A1 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
| 08/27/1997 | EP0702793A4 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation |
| 08/27/1997 | EP0641216B1 PHARMACEUTICAL COMPOSITIONS CONTAINING IL-6 stabilized with a non-reducing sugar |
| 08/27/1997 | EP0607231B1 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1158089A Pegylation reagents and compounds formed therewith |
| 08/27/1997 | CN1158088A Cyclodextrin cellular delivery system for oligonuceleotides |
| 08/27/1997 | CN1158084A Scopolamine plaster |
| 08/27/1997 | CN1158083A Patch for external use |
| 08/27/1997 | CN1158082A Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 08/27/1997 | CA2198576A1 Pharmaceutical composition which comprises hirudin, and process for preparing it |
| 08/26/1997 | US5661131 Administering a vibrio toxin-binding oligosaccharide bound to an absorbent solid support by a nonpeptidyl spacer arm; elimination from the gastrointestinal tract |
| 08/26/1997 | US5661130 Nontoxic, nonionic alkyl glycoside having a hydrophobic alkyl joined by a linkage to a hydrophilic saccharide |
| 08/26/1997 | US5661127 Peptide compositions with growth factor-like activity |
| 08/26/1997 | US5661125 Stable and preserved erythropoietin compositions |
| 08/26/1997 | US5661104 Preservative compositions for use in aqueous systems |
| 08/26/1997 | US5661025 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 08/26/1997 | US5661020 Carboxylation; activation; covalently attaching to superoxide dismutase |
| 08/26/1997 | US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation |
| 08/26/1997 | US5660900 Inorganically filled, starch-bound compositions for manufacturing containers and other articles having a thermodynamically controlled cellular matrix |
| 08/26/1997 | US5660865 Surface treatment composition |
| 08/26/1997 | US5660861 Effective therapy for epilepsies |
| 08/26/1997 | US5660860 Acyclovir in water dispersible tablet; herpes virus treatment |
| 08/26/1997 | US5660859 Gelation of low-molecular weight polymer in water using calcium acetate at room temperature; drug capsules; dental products; cosmetics; cariers |
| 08/26/1997 | US5660856 Pharmaceutical formulation and process |
| 08/26/1997 | US5660851 Covalent attachmentof a carboxylic acid-containing active material through anhydride bonds to a polymer that contains pendant carboxylic acid groups; drug delivery |
| 08/26/1997 | US5660849 Kit comprising support for maintaining polymer thereon, means for compressing polymer, vials containing water coagulable thermoplastic polymer in water soluble organic solvent, aqueous medium |
| 08/26/1997 | US5660846 Methods and apparatus for the delivery of solid drug compositions |
| 08/26/1997 | US5660845 Solid consumer product compositions containing small particle cyclodextrin complexes |
| 08/26/1997 | US5660839 Consists of an oil and/or wax, and a defoamble hollow particulate comprising a terpolymer of acrylonitrile-vinylidene chloride and a (meth) acrylate; used for topical application to human hair or skin |
| 08/26/1997 | US5660837 Preparing pharmaceutical formulation in form of oil-in-water emulsion |
| 08/26/1997 | US5660829 Process for antibody directed enzyme prodrug therapy |
| 08/26/1997 | US5660827 Antibodies that bind to endoglin |
| 08/26/1997 | US5660823 Fast drying, film forming iodine release solution |
| 08/26/1997 | US5660822 Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use |
| 08/26/1997 | US5659984 Adapted to be attached to a vehicle |
| 08/26/1997 | CA1339347C Particulate compositions comprising active ingredient in polymer |
| 08/21/1997 | WO1997030148A1 Conjugation of polypeptides |
| 08/21/1997 | WO1997030074A1 Isolation and use of sh3 binding peptides |